1. Home
  2. WVVI vs LGVN Comparison

WVVI vs LGVN Comparison

Compare WVVI & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVVI
  • LGVN
  • Stock Information
  • Founded
  • WVVI 1983
  • LGVN 2014
  • Country
  • WVVI United States
  • LGVN United States
  • Employees
  • WVVI N/A
  • LGVN N/A
  • Industry
  • WVVI Beverages (Production/Distribution)
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • WVVI Consumer Staples
  • LGVN Health Care
  • Exchange
  • WVVI Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • WVVI 28.2M
  • LGVN 23.4M
  • IPO Year
  • WVVI N/A
  • LGVN 2021
  • Fundamental
  • Price
  • WVVI $5.00
  • LGVN $1.30
  • Analyst Decision
  • WVVI
  • LGVN Strong Buy
  • Analyst Count
  • WVVI 0
  • LGVN 3
  • Target Price
  • WVVI N/A
  • LGVN $8.67
  • AVG Volume (30 Days)
  • WVVI 21.3K
  • LGVN 138.8K
  • Earning Date
  • WVVI 08-12-2025
  • LGVN 08-13-2025
  • Dividend Yield
  • WVVI N/A
  • LGVN N/A
  • EPS Growth
  • WVVI N/A
  • LGVN N/A
  • EPS
  • WVVI N/A
  • LGVN N/A
  • Revenue
  • WVVI $38,520,945.00
  • LGVN $2,225,000.00
  • Revenue This Year
  • WVVI N/A
  • LGVN N/A
  • Revenue Next Year
  • WVVI N/A
  • LGVN $51.48
  • P/E Ratio
  • WVVI N/A
  • LGVN N/A
  • Revenue Growth
  • WVVI N/A
  • LGVN 127.50
  • 52 Week Low
  • WVVI $3.17
  • LGVN $1.14
  • 52 Week High
  • WVVI $7.18
  • LGVN $6.40
  • Technical
  • Relative Strength Index (RSI)
  • WVVI 29.26
  • LGVN 50.13
  • Support Level
  • WVVI $4.50
  • LGVN $1.15
  • Resistance Level
  • WVVI $6.05
  • LGVN $1.32
  • Average True Range (ATR)
  • WVVI 0.45
  • LGVN 0.09
  • MACD
  • WVVI -0.10
  • LGVN 0.01
  • Stochastic Oscillator
  • WVVI 18.66
  • LGVN 45.31

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: